ErbB3 Overexpression Predicts Survival in Primary Colorectal Cancer

被引：0
|
作者：
Bocicariu, Alina
Ren, Kevin Yi Mi
Ramjeesingh, Ravi
Hammad, Nazik
Biagi, James J.
Nicol, Christopher
Mulligan, Lois
Feilotter, Harriet
Hurlbut, David
Davey, Scott
机构：
[1] Queens Univ, Kingston, ON, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
643
引用
收藏
页码：162A / 162A
页数：1
相关论文
共 50 条
  • [1] ErbB3 Overexpression Predicts Survival in Primary Colorectal Cancer
    Bocicariu, Alina
    Ren, Kevin Yi Mi
    Ramjeesingh, Ravi
    Hammad, Nazik
    Biagi, James J.
    Nicol, Christopher
    Mulligan, Lois
    Feilotter, Harriet
    Hurlbut, David
    Davey, Scott
    [J]. MODERN PATHOLOGY, 2017, 30 : 162A - 162A
  • [2] OVEREXPRESSION OF DICER PREDICTS SURVIVAL IN COLORECTAL CANCER
    Faber, C.
    Horst, D.
    Hlubek, F.
    Kirchner, T.
    [J]. TUMOR BIOLOGY, 2010, 31 : S105 - S105
  • [3] Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
    Loree, Jonathan M.
    Bailey, Ann M.
    Johnson, Amber M.
    Yu, Yao
    Wu, Wenhui
    Bristow, Christopher A.
    Davis, Jennifer S.
    Shaw, Kenna R.
    Broaddus, Russell
    Banks, Kimberly C.
    Lanman, Richard B.
    Meric-Bernstam, Funda
    Overman, Michael J.
    Kopetz, Scott
    Raghav, Kanwal
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (12) : 1409 - 1417
  • [4] Overexpression of Dicer predicts poor survival in colorectal cancer
    Faber, C.
    Horst, D.
    Hlubek, F.
    Kirchner, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1414 - 1419
  • [5] ERBB3 Multifunctional enabler or primary actor in pancreatic cancer?
    Landgraf, Ralf
    [J]. CANCER BIOLOGY & THERAPY, 2010, 10 (06) : 564 - 566
  • [6] Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
    Yao, Yong-Liang
    Shao, Jie
    Zhang, Chunfu
    Wu, Jian-Hong
    Zhang, Qing-Hui
    Wang, Jian-Jun
    Zhu, Wei
    [J]. PLOS ONE, 2013, 8 (10):
  • [7] Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer
    Koumakpayi, Ismael H.
    Diallo, Jean-Simon
    Le Page, Cecile
    Lessard, Laurent
    Filali-Mouhim, Abdelali
    Begin, Louis R.
    Mes-Masson, Anne-Marie
    Saad, Fred
    [J]. BJU INTERNATIONAL, 2007, 100 (02) : 303 - 309
  • [8] ErbB-3 predicts survival in ovarian cancer
    Tanner, Berno
    Hasenclever, Dirk
    Stern, Katja
    Schormann, Wiebke
    Bezler, Martin
    Hermes, Matthias
    Brulport, Marc
    Bauer, Alexander
    Schiffer, Ilka B.
    Gebhard, Susanne
    Schmidt, Markus
    Steiner, Eric
    Sehouli, Jalid
    Edelmann, Jeanett
    Laeuter, Juergen
    Lessig, Ruediger
    Krishnamurthi, K.
    Ullrich, Axel
    Hengstler, Jan Georg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) : 4317 - 4323
  • [9] The interaction between MUC1 and erbB3 promotes erbB3 signaling and cell survival
    Su, Hsin-Yuan
    Schroeder, Joyce A.
    [J]. CANCER RESEARCH, 2010, 70
  • [10] Targeting on ErbB3 for cancer therapy
    Liu, Xifu
    Li, Xingyan
    Zhou, Mingdong
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 8 - 8
12345